New TB vaccine that showed hope for South African infants to be tested on teens in 2024

A novel TB vaccine candidate that could replace the bacille Calmette-Guerin vaccine and has been found to provide significantly better protection against the TB germ in South African newborns, is set to reach a new benchmark in the new year as it will be tested on teenagers and adults with latent TB.

Related Keywords

Spain ,Germany ,South Africa ,Spanish ,South African ,German ,Lew Schrager ,Mark Feinberg ,Melinda Gates Foundation ,International Aids Vaccine Initiative ,Saharan African ,Mtbvac ,Vaccine Candidate ,Tb Vaccine ,Trials ,Tb ,Sa ,Mycobacterium Bovis ,Biofabri ,Calmette Guerin ,Bill And Melinda Gates Foundation ,Sub Saharan African ,Phase Iib ,Phase 3 ,Madagascar ,Senegal ,Vaccine Trials Network ,Mtvac ,Timeslive ,Esteban Rodriguez ,Reaking News ,Eneral ,Politics ,Port ,Entertainment ,Ifestyle ,Eird ,World ,Frica ,News ,Xtra ,Sunday Times ,Times ,He Times ,Usiness Times ,Shisa Live ,